Who Is a Candidate for Percutaneous PFO or ASD Closure, and Who Is Better Served by Surgery?

The stroke was small, the recovery quick, and the answer to the obvious question was frustrating: nobody could say why it happened. A 44-year-old with normal blood pressure, no diabetes and a clean carotid scan does not fit the usual script. Then the echocardiogram showed a flap in the wall between the upper chambers of the heart, and a new question arrived at the kitchen table: should that flap be closed, and by whom?

Working out who is a candidate for PFO closure, or for closure of its larger cousin the atrial septal defect, is not a single test result. It is a chain of evidence that a stroke team, a cardiologist and an imaging specialist build together, and it ends with one of three answers: close it with a catheter, close it in the operating room, or leave it alone and treat with medicine.

This explainer walks through how that chain is built, where the evidence is strong, where it is still thin, and what the weeks afterward tend to look like.

What a PFO and an ASD actually are, and why the difference matters

Every baby is born with a small tunnel between the two upper chambers of the heart. The foramen ovale lets blood bypass the lungs before birth, when the lungs are not yet breathing. In most people the flap seals within the first months of life. When it stays open into adulthood it is called a patent foramen ovale, or PFO; “patent” is simply the medical word for open. The Mayo Clinic and Cleveland Clinic both put the figure at roughly 1 in 4 adults, which means a PFO is a normal variant far more often than it is a disease.

An atrial septal defect, or ASD, is different. Rather than a flap that failed to seal, it is a true gap in the septum, the wall that separates the right and left atria. The gap lets oxygen-rich blood from the left atrium flow back into the right side, so the right heart and lungs handle more blood than they should. Over years that extra volume can stretch the right atrium and ventricle, strain the lung circulation and set the stage for rhythm problems. Cleveland Clinic lists ASD among the most common congenital heart defects diagnosed in adults, partly because small ones cause no symptoms for decades.

The distinction shapes everything that follows. A PFO rarely stretches the heart; the concern is that a clot from the veins can slip through the flap and travel to the brain, a mechanism called paradoxical embolism. An ASD is judged mainly by how much blood is crossing and what it is doing to the right heart. Two holes in the same wall, two entirely different reasons to consider closing them.

There is also an anatomical wrinkle that decides catheter versus surgery. ASDs come in several types: secundum (in the center of the wall), primum (low, near the valves), sinus venosus (high, near where the great veins enter) and the rare coronary sinus defect. Only secundum defects have the ring of tissue a device needs to grip.

PFO closure: who is a candidate after a stroke?

The clearest indication comes from stroke neurology, not cardiology. The American Academy of Neurology’s practice advisory, published in Neurology and indexed on PubMed, concluded that closure may be recommended for people under 60 who have had an embolic-appearing ischemic stroke, a PFO on imaging, and no other mechanism found after a thorough search. That last clause carries most of the weight. Before a PFO is blamed, the team is expected to have looked hard for atrial fibrillation with prolonged rhythm monitoring, examined the neck and brain arteries, checked for small-vessel disease, and screened for clotting disorders where relevant.

Why under 60? The randomized trials that showed benefit enrolled younger adults with few vascular risk factors. In that group a PFO is a plausible culprit because the usual suspects are absent. Past 60, alternative explanations become common, and the evidence for closure thins out. The advisory does not forbid closure in older patients; it says the data do not support a general recommendation.

Anatomy tips the scales too. Features that make a PFO more likely to have been the route for a clot include a large opening on bubble study (a test in which agitated saline is injected into a vein while an ultrasound watches for bubbles crossing to the left side), a large shunt at rest, and an atrial septal aneurysm, meaning a floppy, redundant portion of septal tissue. Several trials weighted enrollment toward these higher-risk features.

Evidence of a leg or pelvic vein clot at the time of the stroke strengthens the case still further, because it supplies the missing first half of the story: the clot that needed a doorway. Put together, a candidate for PFO closure after stroke is someone young enough, with an imaging pattern that looks embolic, an anatomy that looks capable, and a workup that has run out of other explanations.

Who is usually asked to wait, or told closure is not the answer

Not every PFO plus stroke adds up to a closure. Teams commonly hold back in several situations, and the reasons deserve plain explanation rather than a flat no.

The most frequent is an unfinished workup. If rhythm monitoring has run for only a day or two, a hidden episode of atrial fibrillation may still be waiting to be found. Atrial fibrillation is a far more common stroke cause than a PFO in adults over 50, and closing the flap does nothing for it. Many neurologists ask for weeks of ambulatory monitoring, or an implanted loop recorder, before they are satisfied. Waiting here is not indecision; it is the difference between treating the actual cause and treating a bystander.

A second group has a competing explanation already in hand: significant narrowing of a carotid artery, a small deep infarct typical of small-vessel disease, or a known clotting disorder that calls for long-term anticoagulation anyway. When the stroke has a better-fitting story, the PFO is usually left alone.

People who have never had a stroke or transient ischemic attack make up a third group. A PFO found by chance during an echocardiogram for some other reason is, by the numbers, one of the 25 percent of normal hearts the Mayo Clinic describes. Preventive closure in someone with no event has not been shown to help and exposes a healthy person to procedural risk.

Finally, a small number of people have anatomy that a device cannot safely seat in: a PFO tunnel that is unusually long or rigid, or an associated defect that changes the plan. For them the conversation shifts toward medicine or, occasionally, surgery.

In every case the treating team weighs the individual picture. A wait is often a wait for information, and the question can be reopened when that information arrives.

How percutaneous closure works, step by step

Percutaneous means through the skin. There is no chest incision and the heart keeps beating throughout. Cleveland Clinic and the Mayo Clinic describe a procedure that usually takes one to two hours and is often done with sedation, though general anesthesia is common when an ultrasound probe is placed in the esophagus to guide the work.

The interventional cardiologist enters a vein at the top of the leg, most often the femoral vein, with a needle and a short plastic sheath. A thin, flexible tube called a catheter is advanced along the vein into the right atrium under X-ray guidance. Because veins carry blood back toward the heart, the catheter arrives on the right side naturally, and the hole is right there in the wall.

Imaging then takes over. Either transesophageal echocardiography (an ultrasound probe passed down the throat to sit just behind the heart) or intracardiac echocardiography (a miniature ultrasound catheter inside the heart itself) shows the hole, its rims and its size. For an ASD the operator may inflate a soft measuring balloon in the defect to confirm the diameter. Device selection depends entirely on these measurements.

The closure device is a self-expanding double disc, most often a fine wire mesh with a fabric core, folded inside a delivery catheter. The catheter crosses the hole, the first disc is opened on the left side, the assembly is drawn back so that disc hugs the wall, and the second disc is deployed on the right. The two discs clamp the septum like a collar button. Before release, the operator tugs gently and checks with ultrasound that the device is stable and no significant flow persists. Once released, the catheter is withdrawn and pressure is applied to the leg.

Over the following months the body’s own tissue grows across the mesh, a process called endothelialization. Cleveland Clinic notes that this coverage is generally complete by around six months, which is why the medicine and endocarditis precautions discussed later are timed as they are.

ASD closure: which holes a catheter can close and which need a surgeon

For ASD the first question is not whether to close but whether the shunt is large enough to matter. Cleveland Clinic describes the usual triggers: evidence that the right atrium and right ventricle are enlarged, a significant amount of blood crossing left to right on echocardiography, or symptoms such as breathlessness and reduced stamina attributed to the defect. Small ASDs without right-heart enlargement are often simply followed with periodic echocardiograms, because some close spontaneously in childhood and small adult defects may never cause harm.

Once closure is judged worthwhile, anatomy decides the route. A secundum ASD, sitting in the central part of the septum, can be closed with a catheter device when it has adequate rims: a ring of firm septal tissue around most of its circumference so that the discs have something to grip. Cardiologists assess these rims on transesophageal echo and pay particular attention to the edge nearest the aorta and the edge nearest the inferior vena cava, where tissue is often thin. Very large secundum defects can exceed what a device can safely span, and the upper limit varies with the device design and the individual heart.

Primum ASDs lie low in the septum and border the mitral and tricuspid valves. They are part of the spectrum of atrioventricular septal defects and often coexist with a cleft in the mitral valve leaflet. A device placed there could interfere with valve function, so these are repaired surgically, usually with valve repair at the same time.

Sinus venosus defects sit high, where the superior vena cava enters, and are frequently accompanied by a pulmonary vein draining to the wrong atrium. Correcting that rerouting requires a surgeon. Coronary sinus defects, which are rare, are likewise surgical.

The practical upshot: many adult ASDs are secundum and device-friendly, but the imaging report, not the label “ASD”, tells the team which door to walk through.

When is open-heart surgery the better choice?

Surgical closure is older, more invasive and, for the right patient, still the correct answer. The Mayo Clinic describes it as the standard approach for ASD types other than secundum and for defects that a device cannot secure. Understanding the specific situations helps people see why a surgeon might be recommended even when a neighbor “had it done through the leg.”

The first is anatomy the device cannot handle: primum, sinus venosus and coronary sinus defects, and secundum defects with deficient rims or a diameter beyond what devices are designed for. The surgeon can sew a patch of the patient’s own pericardium or synthetic material directly across the gap and, where needed, redirect a misplaced pulmonary vein or repair a cleft valve.

The second is company. If the person also needs a valve repair, coronary bypass or another structural correction, closing the septal defect during the same operation avoids a second procedure. A PFO discovered during heart surgery for another reason is often simply stitched shut because the heart is already open.

The third is failure or complication of a prior device: a residual leak that matters, a device that has eroded through tissue, or a clot that will not resolve. These are uncommon, but when they occur surgery is the usual remedy.

What surgery involves is more demanding. The chest is opened, traditionally through the breastbone though smaller right-sided incisions are used in selected cases, and the heart is stopped while a heart-lung machine takes over circulation. The Mayo Clinic describes a hospital stay of several days and a recovery period of several weeks before full activity, compared with a night or two and roughly a week for catheter closure.

The trade-off is thoroughness. Surgery can close anything and fix what lies beside it. Catheter closure is gentler on the body but only works on the anatomy it was built for. The choice belongs to a team that has seen the images.

ASD closure vs surgery: a side-by-side summary

The table below collects the practical differences people most often ask about. It is a general guide drawn from Cleveland Clinic and Mayo Clinic patient information; individual plans vary, and the treating team’s assessment of your anatomy always overrides a summary.

Question	Percutaneous (catheter) closure	Surgical closure
Which defects	PFO; secundum ASD with adequate rims	All ASD types; PFO found during other heart surgery; failed devices
Access	Needle puncture in a leg vein	Chest incision; heart-lung machine
Anesthesia	Sedation or general, depending on imaging used	General
Typical procedure length	About 1–2 hours	Several hours including bypass
Typical hospital stay	Same day or one night	Several days
Return to routine activity	Around a week for most; heavy lifting restricted longer	Several weeks; sternal precautions if breastbone opened
Can fix associated problems	No	Yes (valve repair, venous rerouting, other defects)
Main early risks	Groin bleeding or bruising, device movement, temporary arrhythmia, clot on device, rare erosion	Bleeding, infection, fluid around heart, arrhythmia, anesthesia-related risks
Follow-up imaging	Echo at intervals, usually including around 6 months	Echo at intervals

Two rows deserve a second look. “Can fix associated problems” is often the deciding factor for adults with ASD, because by the time a defect is found in a 55-year-old the tricuspid valve may have stretched or the rhythm may have become irregular. And the recovery rows should be read as typical ranges, not promises; age, lung health and other conditions change them.

Neither column is “better.” Each is better for a particular heart.

How risky is closing a PFO? What the trials actually showed

Risk is where honest numbers matter most, so here are the ones that come with a named source. The American Academy of Neurology advisory pooled the randomized trials of PFO closure after cryptogenic stroke and reported that closure reduced the absolute risk of recurrent stroke by about 3.4 percent over five years compared with medical therapy alone. That figure is worth turning over. It means that for every 100 people closed, roughly three or four avoided a second stroke who would otherwise have had one, while the great majority would have been fine either way because recurrence rates in this young group were already low.

Against that benefit, the same advisory reported a periprocedural complication rate of about 3.9 percent across trials. Most complications were minor or transient: bleeding or bruising at the groin, a brief episode of irregular rhythm, a small collection of fluid around the heart that resolved on its own. Serious events such as device dislodgement, perforation or erosion of the atrial wall, or clot forming on the device were uncommon but real, and are the reason closure is not offered casually.

Atrial fibrillation deserves its own line. The trials found a small increase in new atrial fibrillation after device closure, concentrated in the first weeks. Most episodes settled, but any new irregular heartbeat after closure is taken seriously because it is itself a stroke risk factor.

Longer-term device concerns include nickel allergy reactions in a minority of people with known sensitivity, and the very rare erosion mentioned above, which is why teams check anatomy so carefully before implanting. Cleveland Clinic and the Mayo Clinic both describe device closure as generally safe with a low overall complication rate, while listing these same possibilities.

Is PFO closure risky? Less than most heart procedures, but not risk-free, and the modest absolute benefit is exactly why the selection criteria are strict. The people who gain the most are the ones the evidence was built on.

PFO closure recovery time: what the following days and weeks usually look like

People are often surprised by how ordinary the first day feels. After catheter closure the Mayo Clinic describes a few hours lying flat while the vein puncture seals, an overnight stay in many centers, and discharge the next morning. Some programs send suitable patients home the same day. The groin may be tender and bruised for a week or so; a lump the size of a walnut that shrinks over days is common and is usually a small collection of blood under the skin.

Chest sensations in the first weeks are frequent and usually benign: a fluttering awareness of the heartbeat, occasional skipped beats, a vague chest ache. The device is a new object against the septum, and the heart notices. Persistent palpitations, however, are reported to the team because of the atrial fibrillation risk described earlier.

Activity restrictions are practical rather than dramatic. Cleveland Clinic advises avoiding heavy lifting and strenuous exercise for roughly a week to let the vein heal, then a gradual return to normal exercise. Most people who work at a desk are back within days; those with physical jobs wait for clearance.

Follow-up imaging is the anchor of the recovery calendar. A transthoracic echocardiogram is typically performed before discharge to confirm the device position, then again at intervals the team sets, commonly including a check around six months when tissue coverage of the device is expected to be complete. A bubble study at that visit looks for any residual shunt. Small leaks in the first months often close as tissue grows in.

Surgical recovery runs on a longer clock. The Mayo Clinic describes several days in hospital and several weeks before full activity, with sternal precautions such as avoiding pushing, pulling and lifting while the breastbone knits, typically over about six to eight weeks. Breathing exercises, walking that increases daily, and wound care make up most of the early homework.

Every timeline here is a typical range. Your team will adjust it to your heart, your lungs and how the procedure went.

Medicines after closure: what they do and why the timing matters

Medicine after a septal closure is not optional wallpaper; it does specific jobs during specific windows. This section explains the mechanisms so the conversation with the prescribing clinician makes sense. It does not suggest what to take or for how long; that belongs to the team that knows your history.

The first job is preventing clot on the device. Until the body’s own lining grows across the mesh, the bare surface can attract platelets, the tiny cells that start a clot. Antiplatelet medicines, the class that makes platelets less sticky, are commonly prescribed for the months when this risk is highest. Cleveland Clinic describes this period as typically lasting several months while the device becomes covered, after which the clinician decides whether any antiplatelet therapy should continue for other reasons, such as general vascular protection.

Some people were already taking an anticoagulant, the class that slows the clotting cascade itself, because of a leg vein clot or a clotting disorder found during the stroke workup. Whether that continues after closure, and for how long, depends on the reason it was started, not on the device. Closing the PFO removes the doorway, not the tendency to form clots.

The second job is protecting against endocarditis, an infection of the heart’s inner lining that can seed on foreign material. Guidelines followed by the Mayo Clinic and Cleveland Clinic advise antibiotic prophylaxis before certain dental procedures during the first six months after device closure, the window before the device is covered. After that, prophylaxis is generally no longer advised for an uncomplicated, fully sealed closure, though a residual leak next to the device can extend it.

A third, less discussed job belongs to any rhythm medicine started if atrial fibrillation appears after the procedure. Because that arrhythmia is often transient, the plan is frequently reviewed at follow-up rather than set permanently.

If a prescription is unclear, ask what it is protecting against and what would prompt a change. Do not stop or adjust anything without the prescribing clinician.

Migraine, diving and other reasons people ask for PFO closure

Stroke prevention is the only indication for PFO closure with randomized-trial support. Several other conditions are linked to PFO in observational studies, and people understandably ask whether closing the flap would help. The honest answer for each is: possibly, but not proven.

Migraine with aura is the most common request. PFO is found more often in people with aura than in the general population, and case series described migraines improving after closure. When randomized, sham-controlled trials tested the idea, the results were disappointing: closure did not meet its primary goal of reducing migraine days in the main studies, with hints of benefit in subgroups that have not been confirmed. The American Academy of Neurology advisory does not recommend PFO closure for migraine outside a research setting, and the Mayo Clinic describes the connection as unproven.

Decompression illness in divers is a second area. Bubbles that form in venous blood after a dive can cross a PFO and reach the brain or spinal cord, and divers with large PFOs appear to have a higher rate of certain decompression injuries. Whether closure lowers that risk has not been tested in randomized trials. Diving medicine specialists tend to individualize advice, which may include conservative dive profiles rather than a procedure. Anyone weighing this should discuss it with a physician experienced in diving medicine alongside the cardiologist.

Platypnea-orthodeoxia, a rare syndrome in which oxygen levels fall when a person sits or stands because blood is shunting right to left across the PFO, is one of the few non-stroke situations where closure is regularly offered, because the mechanism is direct and the improvement can be seen on a pulse oximeter. Cleveland Clinic lists this among recognized reasons for closure.

Cryptogenic stroke remains the anchor. When someone asks whether their PFO should be closed for a reason other than stroke, the team’s job is to say clearly how much evidence stands behind the answer.

PFO closure criteria: how the workup makes the decision

Deciding who is a candidate for PFO closure is a process with recognizable stages, and knowing them helps people understand why the answer can take weeks.

Stage one is confirming the stroke and its pattern. Brain MRI shows whether the infarct looks embolic, meaning a clot travelled from elsewhere and lodged in a surface artery, or looks like small-vessel disease deep in the brain. Only the former points toward a PFO. A transient ischemic attack, where symptoms resolved and the scan is clean, is harder to classify, and many teams weigh it less heavily unless the story is unambiguous.

Stage two is the search for other causes. Neck and intracranial arteries are imaged. Heart rhythm is monitored for an extended period. Blood tests may screen for clotting disorders, especially in younger people or those with a personal or family history of venous clots. Leg vein ultrasound is sometimes added to look for the source clot that would complete the paradoxical embolism story.

Stage three is characterizing the PFO. Transthoracic echo with a bubble study, and often transesophageal echo, measure how much crosses, whether it crosses at rest or only with a strain maneuver, and whether an atrial septal aneurysm is present. Some teams use a validated scoring system that combines age, vascular risk factors and imaging features to estimate how likely the PFO is to be causal rather than incidental. A high score supports closure; a low score suggests the PFO is a bystander.

Stage four is the shared decision. The American Academy of Neurology advisory is explicit that neurologist and cardiologist should agree, and that the patient should hear the absolute numbers: roughly a 3.4 percent absolute reduction in recurrent stroke over five years against a periprocedural complication rate near 3.9 percent, with a small increase in atrial fibrillation. Some people hear those numbers and choose closure; others prefer antiplatelet therapy. Both are reasonable choices within the evidence, and the treating team supports either.

What people often get wrong about PFO and ASD closure

Misunderstandings cluster around a few ideas, and each has a factual correction.

“I have a hole in my heart, so it must be closed.” A PFO is present in roughly 1 in 4 adults according to the Mayo Clinic, the vast majority of whom will never have a related problem. Closure without a stroke or another accepted indication has no demonstrated benefit and carries procedural risk. A small ASD without right-heart enlargement is likewise commonly observed rather than closed.

“Closing the PFO means I will never have another stroke.” Closure reduces recurrence in selected patients; it does not eliminate it. The pooled trials showed a modest absolute reduction, and strokes from other causes remain possible. Blood pressure, cholesterol, smoking and diabetes still matter after the device is in.

“The device is a mechanical part that will wear out.” Closure devices are designed to be permanent. Within months they are covered by the body’s own tissue and become part of the septum. They do not have moving parts and are not replaced on a schedule. Follow-up imaging checks position and residual flow, not wear.

“Surgery is the old way and catheter closure has replaced it.” Surgery remains the standard route for primum, sinus venosus and coronary sinus defects, for large or rim-deficient secundum defects, and whenever another repair is needed. Being sent to a surgeon is a match to anatomy, not a downgrade.

“Closing my PFO will fix my migraines.” Randomized trials did not confirm this, and the American Academy of Neurology does not recommend closure for migraine outside research.

“I can stop the blood thinner once the hole is closed.” Whether antiplatelet or anticoagulant therapy continues depends on why it was started. Only the prescribing clinician should make that call.

“Children cannot have catheter closure.” Secundum ASDs in children are frequently closed by catheter once the child is large enough for the device and delivery system, with the same anatomical criteria applied.

Questions to ask your care team before deciding

A good consultation leaves you able to explain the plan to someone else. These questions help get there, and none of them is unreasonable to ask.

• Has my stroke workup ruled out atrial fibrillation with prolonged monitoring, and for how long was my rhythm recorded?
• Does my brain imaging look embolic, and what other causes were considered and excluded?
• Which type of defect do I have: PFO, secundum, primum, sinus venosus or another? What does that mean for catheter versus surgery?
• What did the echo show about the size of the shunt, the rims around the defect, and whether there is an atrial septal aneurysm?
• Is my right heart enlarged, and how will you follow that if we choose observation?
• In my specific case, what is the estimated absolute benefit of closure versus medicine alone, and how confident is the evidence for someone my age?
• What complications are you most concerned about for my anatomy, and how often does your team see them?
• If a device is used, which medicines would follow, what does each protect against, and when would each be reviewed?
• Would I need antibiotic precautions before dental work, and for how long?
• How many follow-up echocardiograms should I expect, and what would a residual leak mean?
• If surgery is recommended, why is a device not suitable for me, and what else would be repaired at the same time?
• How will a new irregular heartbeat after the procedure be handled?
• Are there activities, sports or travel I should postpone, and for roughly how long?
• If I decline closure now, can the decision be revisited, and what would change it?

Bring a notebook or a companion. Ask the team to draw the septum and point to where your defect sits; most cardiologists do this gladly, and the sketch usually clarifies more than a paragraph of explanation. The point of the conversation is not to reach a particular answer but to make sure the answer you reach is yours and the team’s together.

When to call your doctor: red-flag signs after PFO or ASD closure

Most recoveries are uneventful, and knowing which symptoms matter spares needless worry while catching the few that need action. The Mayo Clinic and Cleveland Clinic list similar warning signs; the ones below apply after either catheter or surgical closure unless noted.

Call emergency services immediately, do not drive yourself, if you notice sudden weakness or numbness of the face, arm or leg, especially on one side; sudden trouble speaking or understanding; sudden loss of vision or double vision; a sudden severe headache unlike any before; or sudden loss of balance. These are stroke signs, and time to treatment matters.

Also seek emergency care for chest pain that is new, severe or spreading to the arm, neck or jaw; sudden shortness of breath or breathing that worsens when lying flat; fainting or near-fainting; a heartbeat that is very fast, very slow or irregular and accompanied by dizziness, chest discomfort or breathlessness; or bleeding from the leg puncture site that does not stop with firm pressure for several minutes.

Contact your care team the same day for a growing, tense or painful swelling at the groin; a leg that becomes cold, pale or numb below the puncture; a fever, chills or feeling unwell without an obvious cause, which after a device implant can signal infection and should not be waited out; palpitations that persist for more than a few minutes or keep returning; after surgery, redness, warmth, drainage or separation of the wound, or a clicking sensation in the breastbone.

Less urgent but still worth a message: a low-grade ache in the chest that lingers beyond the first weeks, new swelling of both ankles, or a return of breathlessness after it had improved. None of these should be self-managed with over-the-counter remedies for long before the team is told.

When in doubt, call. Nurses and cardiologists field these questions every day and would rather hear about ten benign symptoms than miss one that is not. The plan, the medicines and the timelines belong to your treating team, and so does the judgement about which symptoms change them.

Frequently asked questions

Who qualifies for PFO closure?

The best-supported candidates are adults under about 60 who have had an ischemic stroke that looks embolic on imaging, have a PFO, and have had a thorough workup that found no other cause, including extended heart rhythm monitoring. Features such as a large shunt or an atrial septal aneurysm strengthen the case. People with a PFO but no stroke, or with another clear stroke cause, are not usually offered closure.

Is PFO closure risky?

It carries a low but real risk. In the pooled randomized trials summarized by the American Academy of Neurology, about 3.9 percent of patients had a periprocedural complication, most of them minor such as groin bruising or a brief rhythm disturbance. Rare serious events include device movement, perforation, erosion and clot on the device. A small increase in atrial fibrillation, mostly early and transient, was also seen.

What is the life expectancy of someone who has a PFO closure procedure?

No study can promise an individual lifespan, and closure is not done to extend life directly. The evidence shows that in appropriately selected younger stroke survivors, closure reduces the risk of another stroke compared with medicine alone. Long-term outlook after closure is shaped mainly by overall vascular health, blood pressure, cholesterol, smoking and diabetes control, which is why those factors remain part of every follow-up plan.

How painful is a PFO closure?

Catheter closure is usually described as uncomfortable rather than painful. The procedure is done under sedation or general anesthesia, so the work inside the heart is not felt. Afterward the groin puncture site is typically sore and bruised for several days, and some people notice chest awareness or occasional skipped beats for a few weeks. Surgical closure involves incisional pain that is greater and lasts longer, managed by the surgical team.

What is the PFO closure recovery time?

Most people go home the same day or after one night and return to routine activity within about a week, with heavy lifting and strenuous exercise avoided until the leg vein has healed, according to Cleveland Clinic and Mayo Clinic patient guidance. Follow-up echocardiograms are scheduled at intervals, commonly including a check around six months when tissue coverage of the device is expected. Surgical recovery takes several weeks.

What are the main PFO closure criteria doctors use?

Teams look at age, the pattern of the stroke on brain imaging, whether other causes such as atrial fibrillation or artery disease have been excluded, and the anatomy of the PFO on echocardiography, including shunt size and the presence of an atrial septal aneurysm. Some use a validated score combining these factors to estimate how likely the PFO caused the stroke. A neurologist and cardiologist usually agree jointly before closure is offered.

ASD closure vs surgery: how is the choice made?

Anatomy decides. Secundum ASDs with enough surrounding tissue for a device to grip are usually closed by catheter. Primum, sinus venosus and coronary sinus defects, very large secundum defects, and defects with deficient rims are closed surgically. Surgery is also chosen when another repair, such as a valve or pulmonary vein correction, is needed at the same time, or when a previous device has failed.

Can an ASD or PFO close on its own?

Small secundum ASDs found in infancy often close spontaneously in the first years of life, which is one reason small defects in children are frequently observed rather than treated. Defects still present in adulthood do not close on their own. A PFO is a flap that most often seals in infancy; if it remains open into adult life it is considered permanent, though it may cause no problem.

Does closing a PFO help migraine?

Not according to current evidence. Although PFO is more common in people with migraine with aura, randomized sham-controlled trials did not show that closure reduced migraine days in the overall study groups. Hints of benefit in subgroups have not been confirmed. The American Academy of Neurology does not recommend PFO closure for migraine outside a research setting, and mainstream sources describe the link as unproven.

Can a PFO or ASD closure device be removed later?

Devices are designed to be permanent and become covered by the body’s own tissue within months, after which removal requires open-heart surgery. Surgical removal is reserved for uncommon problems such as significant residual leak, erosion, persistent clot or infection that does not respond to treatment. Routine follow-up echocardiograms check that the device is well seated and sealed so such problems are found early.

References

• Cleveland Clinic: Patent Foramen Ovale (PFO)
• Cleveland Clinic: Atrial Septal Defect (ASD)
• PubMed: Practice advisory update summary: Patent foramen ovale and secondary stroke prevention (American Academy of Neurology)
• MedlinePlus: Atrial septal defect (ASD)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.